DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Hydrocortisone acetateis the generic ingredient in nineteen branded drugs marketed by Mylan Speciality Lp, Able, Cenci, Imperium, Parke Davis, Purepac Pharm, Sebela Ireland Ltd, Pharmacia And Upjohn, Pfizer, Akorn, Bel Mar, Watson Labs, Merck, Ingram Pharm, Fera Pharms, Colgate, X Gen Pharms, Monarch Pharms, Genus, Ferndale Labs, Fougera Pharms, and Taro, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.
There are sixty-seven drug master file entries for hydrocortisone acetate. One supplier is listed for this compound.
Recent Clinical Trials for HYDROCORTISONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
|Feinstein Institute for Medical Research||Phase 2|
|University of Texas Southwestern Medical Center||Phase 2|
|National Institutes of Health Clinical Center (CC)||Phase 2|
Pharmacology for HYDROCORTISONE ACETATE
|Drug Class||Corticosteroid |
|Mechanism of Action||Corticosteroid Hormone Receptor Agonists |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Ingram Pharm||DRICORT||hydrocortisone acetate||LOTION;TOPICAL||086207-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Sebela Ireland Ltd||PRAMOSONE||hydrocortisone acetate; pramoxine hydrochloride||CREAM;TOPICAL||085368-001||Approved Prior to Jan 1, 1982||RX||No||No||Start Trial||Start Trial||Start Trial|
|Watson Labs||HYDROCORTISONE ACETATE||hydrocortisone acetate||INJECTABLE;INJECTION||083759-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Purepac Pharm||HYDROCORTISONE ACETATE||hydrocortisone acetate||CREAM;TOPICAL||086050-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Sebela Ireland Ltd||PRAMOSONE||hydrocortisone acetate; pramoxine hydrochloride||LOTION;TOPICAL||085980-001||Approved Prior to Jan 1, 1982||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.